COL1 |
Pancreatic Cancer |
COL1 deletion in myofibroblast pancreatic tumor promotes progression and immunosuppression; CXCR2 and CCR2 inhibition reverses COL1-deletion-induced tumor progression |
[113] |
|
Breast cancer |
Promotes mammary tumor initiation and progression; COX2 may be an effective therapeutic target |
[100,114,115] |
COL7 |
Lung cancer |
Promotes tumor growth and poor prognosis |
[113] |
COL10A1 |
Colorectal cancer |
Promotes tumor growth and metastasis via epithelial–mesenchymal transition (EMT) |
[108] |
COL11A1 |
Breast cancer |
Promotes tumor growth and metastasis |
[116] |
COL12 |
Breast cancer orthotropic mice model |
Promotes metastatic dissemination by decreasing collagen I bundle thickness and tumor stiffness |
[44] |
COL18A1 |
Breast cancer |
Promotes cancer growth and metastasis by interacting with EGFR/ErbB and activating MAPK/ERK1/2 and PI3K/Akt pathways |
[117] |